Our project: CONCAVE
Every year, iGEM brings together hundreds of teams from around the globe in Paris to exchange ideas on how synthetic biology can be used to solve real world problems and shape a better future.
In 2025, Team Freiburg presented CONCAVE, a project designed to revolutionize the production of novel antibodies, essential tools for countless laboratory applications. Today, generating custom antibodies is expensive, monopolized by specialized companies, and still heavily dependent on animal immunization. This not only raises ethical concerns, as animals are repeatedly used in the process, but also limits scientific progress. The lack of accessible alternatives and the reliance on costly, centralized production leaves many labs, especially those with limited funding, without the reagents they need.
CONCAVE aims to change this.
We designed a system that enables researchers to generate custom protein binders as antibody alternatives directly in E. coli. Thus, making binder development faster, cheaper, and accessible to any lab.